Trial Identifier: | D2287R00139 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03963141 |
Start Date: | August 2019 |
Primary Completion Date: | October 2022 |
Study Completion Date: | October 2022 |
Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
United Arab Emirates | Dubai, United Arab Emirates |